AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
209.40
-1.72 (-0.81%)
At close: Mar 27, 2026, 4:00 PM EDT
209.75
+0.35 (0.17%)
Pre-market: Mar 30, 2026, 6:21 AM EDT
AbbVie (ABBV) Revenue by Segment
History
| Date | Immunology | Neuroscience | Hematologic Oncology | Aesthetics | Other Products | Eye Care | Women's Health |
|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 29.07B | 10.32B | 6.68B | 4.87B | 3.76B | 2.18B | - |
| Jun 30, 2025 | 28.24B | 9.84B | 6.69B | 4.92B | 3.63B | 2.19B | - |
| Mar 31, 2025 | 27.58B | 9.32B | 6.65B | 5.03B | 3.56B | 2.21B | - |
| Dec 31, 2024 | 26.68B | 9.00B | 6.56B | 5.18B | 3.65B | 2.24B | - |
| Sep 30, 2024 | 26.34B | 8.58B | 6.37B | 5.25B | 3.70B | 2.18B | - |
| Jun 30, 2024 | 26.08B | 8.26B | 6.20B | 5.25B | 3.79B | 2.26B | - |
| Mar 31, 2024 | 25.92B | 7.99B | 6.04B | 5.24B | 3.78B | 2.35B | - |
| Dec 31, 2023 | 26.14B | 7.72B | 5.92B | 5.29B | 3.81B | 2.42B | - |
| Sep 30, 2023 | 27.11B | 7.33B | 6.04B | 5.21B | 3.82B | 2.42B | - |
| Jun 30, 2023 | 27.98B | 6.96B | 6.18B | 5.27B | 3.85B | 2.44B | - |
| Mar 31, 2023 | 28.37B | 6.74B | 6.35B | 5.26B | 3.88B | 2.54B | - |
| Dec 31, 2022 | 28.92B | 6.53B | 6.58B | 5.33B | 3.85B | 2.70B | - |
| Sep 30, 2022 | 27.75B | 6.47B | 6.82B | 5.45B | 4.30B | 3.07B | - |
| Jun 30, 2022 | 26.77B | 6.37B | 7.04B | 5.40B | 4.67B | 3.32B | - |
| Mar 31, 2022 | 25.68B | 6.17B | 7.20B | 5.47B | 5.08B | 3.52B | - |
| Dec 31, 2021 | 25.28B | 5.93B | 7.23B | 5.23B | 5.49B | 3.57B | 796.00M |
| Sep 30, 2021 | 24.50B | 5.66B | 7.14B | 4.97B | 5.51B | 3.53B | 829.00M |
| Jun 30, 2021 | 23.61B | 5.35B | 7.00B | 4.68B | 5.41B | 3.50B | 866.00M |
| Mar 31, 2021 | 22.81B | 4.62B | 6.78B | 3.73B | 5.18B | 3.00B | 822.00M |
| Dec 31, 2020 | 22.15B | 3.37B | 6.65B | 2.59B | 5.17B | 2.18B | 642.00M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.